WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma PLC Stock

Open Broker Account
$41.67+1.48 (+3.68%)
Updated Oct 4, 2022
RPRX Price
$41.67
Fair Value Price
$45.14
Market Cap
$25.30B
52 Week Low
$34.86
52 Week High
$44.75
P/E
39.31x
P/B
2.43x
P/S
8.12x
PEG
0.69x
Dividend Yield
1.78%
Revenue
$2.26B
Earnings
$466.10M
Gross Margin
100%
Operating Margin
28.83%
Profit Margin
20.6%
Debt to Equity
0.7
Operating Cash Flow
$2B
Beta
0.69
Next Earnings
Nov 8, 2022
Ex-Dividend
N/A
Next Dividend
N/A

RPRX Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RPRX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RPRX ($41.67) is undervalued by 7.69% relative to our estimate of its Fair Value price of $45.14 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
RPRX ($41.67) is not significantly undervalued (7.69%) relative to our estimate of its Fair Value price of $45.14 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
RPRX ($41.67) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more RPRX due diligence checks available for Premium users.

Be the first to know about important RPRX news, forecast changes, insider trades & much more!

RPRX News

Valuation

RPRX fair value

Fair Value of RPRX stock based on Discounted Cash Flow (DCF)
Price
$41.67
Fair Value
$45.14
Undervalued by
7.69%
RPRX ($41.67) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RPRX ($41.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RPRX ($41.67) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RPRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
39.31x
Industry
15.62x
Market
29.05x
RPRX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RPRX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

RPRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.43x
Industry
4.53x
RPRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RPRX price to earnings growth (PEG)

For valuing profitable companies with growth potential
RPRX is good value based... subscribe to Premium to read more.
PEG Value Valuation

RPRX's financial health

Profit margin

Revenue
$536.0M
Net Income
$304.5M
Profit Margin
56.8%
RPRX's Earnings (EBIT) of $651.43M... subscribe to Premium to read more.
Interest Coverage Financials
RPRX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.7B
Liabilities
$7.3B
Debt to equity
0.7
RPRX's short-term assets ($3.50B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RPRX's long-term liabilities ($7.15B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RPRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$575.0M
Investing
-$30.2M
Financing
-$228.3M
RPRX's operating cash flow ($1.99B)... subscribe to Premium to read more.
Debt Coverage Financials

RPRX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RPRX$25.30B+3.68%39.31x2.43x
SGEN$25.67B+1.07%-34.53x8.75x
ALNY$24.15B+2.26%-24.63x137.21x
GMAB$23.30B+4.88%42.87x6.97x
ARGX$20.34B+5.27%-21.02x6.78x

Royalty Pharma Stock FAQ

What is Royalty Pharma's quote symbol?

NASDAQ: RPRX) Royalty Pharma trades on the NASDAQ under the ticker symbol RPRX. Royalty Pharma stock quotes can also be displayed as NASDAQ: RPRX.

If you're new to stock investing, here's how to buy Royalty Pharma stock.

What is the 52 week high and low for Royalty Pharma (NASDAQ: RPRX)?

(NASDAQ: RPRX) Royalty Pharma's 52-week high was $44.75, and its 52-week low was $34.86. It is currently -6.88% from its 52-week high and 19.54% from its 52-week low.

How much is Royalty Pharma stock worth today?

(NASDAQ: RPRX) Royalty Pharma currently has 607,219,969 outstanding shares. With Royalty Pharma stock trading at $41.67 per share, the total value of Royalty Pharma stock (market capitalization) is $25.30B.

Royalty Pharma stock was originally listed at a price of $44.50 in Jun 16, 2020. If you had invested in Royalty Pharma stock at $44.50, your return over the last 2 years would have been -6.36%, for an annualized return of -3.23% (not including any dividends or dividend reinvestments).

How much is Royalty Pharma's stock price per share?

(NASDAQ: RPRX) Royalty Pharma stock price per share is $41.67 today (as of Oct 4, 2022).

What is Royalty Pharma's Market Cap?

(NASDAQ: RPRX) Royalty Pharma's market cap is $25.30B, as of Oct 5, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Royalty Pharma's market cap is calculated by multiplying RPRX's current stock price of $41.67 by RPRX's total outstanding shares of 607,219,969.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.